Upgrade to SI Premium - Free Trial

Unicycive Therapeutics, Inc (UNCY)

6.85 -0.20 (2.84%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form EFFECT Unicycive Therapeutics, June 16, 2026 6:03 AM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Gupta Shalabh K. June 15, 2026 5:25 PM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Kenkare-Mitra Sara June 15, 2026 5:24 PM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Laumas Sandeep June 15, 2026 5:24 PM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Gupta Pramod June 15, 2026 5:24 PM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Townsend John June 15, 2026 5:24 PM - SEC Filing Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Jermasek Douglas June 15, 2026 5:24 PM - SEC Filing Form 8-K Unicycive Therapeutics, For: Jun 05 June 5, 2026 4:19 PM - SEC Filing Form S-3 Unicycive Therapeutics, June 5, 2026 4:16 PM - SEC Filing Unicycive Therapeutics (UNCY) PT Raised to $18 at Benchmark June 2, 2026 8:07 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY) May 27, 2026 6:50 AM - StreetInsider Form 4 Unicycive Therapeutics, For: May 14 Filed by: Kenkare-Mitra Sara May 21, 2026 4:31 PM - SEC Filing Form 4 Unicycive Therapeutics, For: May 14 Filed by: Gupta Shalabh K. May 21, 2026 4:30 PM - SEC Filing Form 4 Unicycive Therapeutics, For: May 14 Filed by: Jermasek Douglas May 20, 2026 4:31 PM - SEC Filing Form 4 Unicycive Therapeutics, For: May 14 Filed by: Townsend John May 20, 2026 4:31 PM - SEC Filing Form 4 Unicycive Therapeutics, For: May 14 Filed by: Gupta Pramod May 20, 2026 4:31 PM - SEC Filing Form 4 Unicycive Therapeutics, For: May 14 Filed by: Laumas Sandeep May 18, 2026 8:58 PM - SEC Filing Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. May 15, 2026 4:49 PM - SEC Filing Unicycive Therapeutics (UNCY) PT Lowered to $37 at Guggenheim May 13, 2026 6:38 AM - StreetInsider Unicycive Therapeutics, Inc (UNCY) Misses Q1 EPS by 54c May 12, 2026 8:05 AM - StreetInsider Form 8-K Unicycive Therapeutics, For: May 12 May 12, 2026 7:52 AM - SEC Filing Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update May 12, 2026 7:05 AM - Globe NewsWire Form 10-Q Unicycive Therapeutics, For: Mar 31 May 12, 2026 6:31 AM - SEC Filing Form S-8 Unicycive Therapeutics, May 6, 2026 6:06 AM - SEC Filing B.Riley Starts Unicycive Therapeutics (UNCY) at Buy May 1, 2026 9:17 AM - StreetInsider Form ARS Unicycive Therapeutics, For: Dec 31 April 30, 2026 7:04 AM - SEC Filing Form DEFA14A Unicycive Therapeutics, April 30, 2026 7:02 AM - SEC Filing Form DEF 14A Unicycive Therapeutics, For: Jun 19 April 30, 2026 7:00 AM - SEC Filing Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference April 9, 2026 7:05 AM - Globe NewsWire Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets April 7, 2026 4:31 PM - StreetInsider Form 8-K Unicycive Therapeutics, For: Apr 06 April 6, 2026 9:12 AM - SEC Filing Unicycive Therapeutics (UNCY) PT Lowered to $15 at Benchmark April 6, 2026 7:21 AM - StreetInsider Unicycive Therapeutics (UNCY) PT Lowered to $40 at Guggenheim April 2, 2026 6:40 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY) April 1, 2026 6:59 AM - StreetInsider Form 8-K Unicycive Therapeutics, For: Mar 30 March 30, 2026 7:29 AM - SEC Filing Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update March 30, 2026 7:05 AM - Globe NewsWire Form 10-K Unicycive Therapeutics, For: Dec 31 March 30, 2026 6:32 AM - SEC Filing Full Article List